Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 110

1.

Comparison of In Vivo and Ex Vivo MRI for the Detection of Structural Abnormalities in a Mouse Model of Tauopathy.

Holmes HE, Powell NM, Ma D, Ismail O, Harrison IF, Wells JA, Colgan N, O'Callaghan JM, Johnson RA, Murray TK, Ahmed Z, Heggenes M, Fisher A, Cardoso MJ, Modat M, O'Neill MJ, Collins EC, Fisher EM, Ourselin S, Lythgoe MF.

Front Neuroinform. 2017 Mar 31;11:20. doi: 10.3389/fninf.2017.00020. eCollection 2017.

2.

A Hierarchical Feature and Sample Selection Framework and Its Application for Alzheimer's Disease Diagnosis.

An L, Adeli E, Liu M, Zhang J, Lee SW, Shen D.

Sci Rep. 2017 Mar 30;7:45269. doi: 10.1038/srep45269.

3.

Medial temporal lobe subregional morphometry using high resolution MRI in Alzheimer's disease.

Wolk DA, Das SR, Mueller SG, Weiner MW, Yushkevich PA; Alzheimer's Disease Neuroimaging Initiative..

Neurobiol Aging. 2017 Jan;49:204-213. doi: 10.1016/j.neurobiolaging.2016.09.011. Epub 2016 Sep 30.

PMID:
27836336
4.

Identify the Atrophy of Alzheimer's Disease, Mild Cognitive Impairment and Normal Aging Using Morphometric MRI Analysis.

Ma X, Li Z, Jing B, Liu H, Li D, Li H; Alzheimer’s Disease Neuroimaging Initiative..

Front Aging Neurosci. 2016 Oct 18;8:243. eCollection 2016.

5.

Presymptomatic cortical thinning in familial Alzheimer disease: A longitudinal MRI study.

Weston PS, Nicholas JM, Lehmann M, Ryan NS, Liang Y, Macpherson K, Modat M, Rossor MN, Schott JM, Ourselin S, Fox NC.

Neurology. 2016 Nov 8;87(19):2050-2057. Epub 2016 Oct 12.

6.

Neuregulin-1 (Nrg1) signaling has a preventive role and is altered in the frontal cortex under the pathological conditions of Alzheimer's disease.

Jiang Q, Chen S, Hu C, Huang P, Shen H, Zhao W.

Mol Med Rep. 2016 Sep;14(3):2614-24. doi: 10.3892/mmr.2016.5542. Epub 2016 Jul 25.

7.

Magnetization transfer contrast imaging detects early white matter changes in the APP/PS1 amyloidosis mouse model.

Praet J, Bigot C, Orije J, Naeyaert M, Shah D, Mai Z, Guns PJ, Van der Linden A, Verhoye M.

Neuroimage Clin. 2016 Jun 16;12:85-92. eCollection 2016.

8.

Longitudinal Analysis of Image Time Series with Diffeomorphic Deformations: A Computational Framework Based on Stationary Velocity Fields.

Hadj-Hamou M, Lorenzi M, Ayache N, Pennec X.

Front Neurosci. 2016 Jun 3;10:236. doi: 10.3389/fnins.2016.00236. eCollection 2016.

9.

Visual short-term memory binding deficit in familial Alzheimer's disease.

Liang Y, Pertzov Y, Nicholas JM, Henley SM, Crutch S, Woodward F, Leung K, Fox NC, Husain M.

Cortex. 2016 May;78:150-64. doi: 10.1016/j.cortex.2016.01.015. Epub 2016 Feb 6.

10.

Inherent Structure-Based Multiview Learning With Multitemplate Feature Representation for Alzheimer's Disease Diagnosis.

Liu M, Zhang D, Adeli E, Shen D.

IEEE Trans Biomed Eng. 2016 Jul;63(7):1473-82. doi: 10.1109/TBME.2015.2496233. Epub 2015 Oct 30.

11.

CHIMERA: Clustering of Heterogeneous Disease Effects via Distribution Matching of Imaging Patterns.

Dong A, Honnorat N, Gaonkar B, Davatzikos C.

IEEE Trans Med Imaging. 2016 Feb;35(2):612-21. doi: 10.1109/TMI.2015.2487423. Epub 2015 Oct 6.

12.

A Subset of Cerebrospinal Fluid Proteins from a Multi-Analyte Panel Associated with Brain Atrophy, Disease Classification and Prediction in Alzheimer's Disease.

Khan W, Aguilar C, Kiddle SJ, Doyle O, Thambisetty M, Muehlboeck S, Sattlecker M, Newhouse S, Lovestone S, Dobson R, Giampietro V, Westman E, Simmons A; Alzheimer’s Disease Neuroimaging Initiative..

PLoS One. 2015 Aug 18;10(8):e0134368. doi: 10.1371/journal.pone.0134368. eCollection 2015.

13.

The antimicrobial protein, CAP37, is upregulated in pyramidal neurons during Alzheimer's disease.

Brock AJ, Kasus-Jacobi A, Lerner M, Logan S, Adesina AM, Anne Pereira H.

Histochem Cell Biol. 2015 Oct;144(4):293-308. doi: 10.1007/s00418-015-1347-x. Epub 2015 Jul 14.

14.

Diffusion imaging changes in grey matter in Alzheimer's disease: a potential marker of early neurodegeneration.

Weston PS, Simpson IJ, Ryan NS, Ourselin S, Fox NC.

Alzheimers Res Ther. 2015 Jul 1;7(1):47. doi: 10.1186/s13195-015-0132-3. eCollection 2015.

15.

The effects of white matter hyperintensities and amyloid deposition on Alzheimer dementia.

Gordon BA, Najmi S, Hsu P, Roe CM, Morris JC, Benzinger TL.

Neuroimage Clin. 2015 Apr 30;8:246-52. doi: 10.1016/j.nicl.2015.04.017. eCollection 2015.

16.

Free Recall Episodic Memory Performance Predicts Dementia Ten Years prior to Clinical Diagnosis: Findings from the Betula Longitudinal Study.

Boraxbekk CJ, Lundquist A, Nordin A, Nyberg L, Nilsson LG, Adolfsson R.

Dement Geriatr Cogn Dis Extra. 2015 May 1;5(2):191-202. doi: 10.1159/000381535. eCollection 2015 May-Aug.

17.

First effects of rising amyloid-β in transgenic mouse brain: synaptic transmission and gene expression.

Cummings DM, Liu W, Portelius E, Bayram S, Yasvoina M, Ho SH, Smits H, Ali SS, Steinberg R, Pegasiou CM, James OT, Matarin M, Richardson JC, Zetterberg H, Blennow K, Hardy JA, Salih DA, Edwards FA.

Brain. 2015 Jul;138(Pt 7):1992-2004. doi: 10.1093/brain/awv127. Epub 2015 May 16.

18.

Integrating Neuropsychology and Brain Imaging for a Referral of Possible Pseudodementia: A Case Report.

Tanner JJ, Mellott E, Dunne EM, Price CC.

Clin Neuropsychol. 2015;29(2):272-92. doi: 10.1080/13854046.2015.1008047. Epub 2015 Feb 6.

19.

Associations between biomarkers and age in the presenilin 1 E280A autosomal dominant Alzheimer disease kindred: a cross-sectional study.

Fleisher AS, Chen K, Quiroz YT, Jakimovich LJ, Gutierrez Gomez M, Langois CM, Langbaum JB, Roontiva A, Thiyyagura P, Lee W, Ayutyanont N, Lopez L, Moreno S, Muñoz C, Tirado V, Acosta-Baena N, Fagan AM, Giraldo M, Garcia G, Huentelman MJ, Tariot PN, Lopera F, Reiman EM.

JAMA Neurol. 2015 Mar;72(3):316-24. doi: 10.1001/jamaneurol.2014.3314.

Supplemental Content

Support Center